tolazoline has been researched along with Oliguria in 5 studies
Tolazoline: A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn.
tolazoline : A member of the class of imidazoles that is 4,5-dihydro-1H-imidazole substituted by a benzyl group.
Oliguria: Decreased URINE output that is below the normal range. Oliguria can be defined as urine output of less than or equal to 0.5 or 1 ml/kg/hr depending on the age.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The combined application of Tolazoline and Dopamine for the treatment of the persistent fetal circulation syndrome showed that Dopamine prevented the most common side effects of Tolazoline i." | 7.66 | [Tolazoline and dopamine in the treatment of the persistent fetal circulation syndrome]. ( Csömör, S; Kiszel, J; Machay, T; Seri, I; Téglás, E; Tulassay, TL, 1983) |
| "Tolazoline treatment of neonates has been reported since 1965." | 5.27 | Oliguria and tolazoline pharmacokinetics in the newborn. ( Daniel, CH; Kendig, JW; Ward, RM; Wood, MA, 1986) |
| "Oliguria in the neonate usually reflects a fall in glomerular filtration rate (GFR) secondary to prerenal disturbances such as hypovolemia, hypotension, hypoxemia and cardiac failure, or to vasoactive drugs such as indomethacin and tolazoline." | 4.77 | Drugs and acute renal insufficiency in the neonate. ( Gouyon, JB; Guignard, JP, 1986) |
| "The combined application of Tolazoline and Dopamine for the treatment of the persistent fetal circulation syndrome showed that Dopamine prevented the most common side effects of Tolazoline i." | 3.66 | [Tolazoline and dopamine in the treatment of the persistent fetal circulation syndrome]. ( Csömör, S; Kiszel, J; Machay, T; Seri, I; Téglás, E; Tulassay, TL, 1983) |
| "Tolazoline treatment of neonates has been reported since 1965." | 1.27 | Oliguria and tolazoline pharmacokinetics in the newborn. ( Daniel, CH; Kendig, JW; Ward, RM; Wood, MA, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seri, I | 2 |
| Tulassay, T | 1 |
| Kiszel, J | 2 |
| Machay, T | 2 |
| Lipták, M | 1 |
| Csömör, S | 2 |
| Tulassay, TL | 1 |
| Téglás, E | 1 |
| Menzel, K | 1 |
| Schambach, K | 1 |
| Töpke, B | 1 |
| Gouyon, JB | 1 |
| Guignard, JP | 1 |
| Ward, RM | 1 |
| Daniel, CH | 1 |
| Kendig, JW | 1 |
| Wood, MA | 1 |
2 reviews available for tolazoline and Oliguria
| Article | Year |
|---|---|
[The patent ductus arteriosus from a perinatological viewpoint].
Topics: Cyclooxygenase Inhibitors; Ductus Arteriosus, Patent; Fetus; Gastrointestinal Hemorrhage; Growth; Hu | 1978 |
Drugs and acute renal insufficiency in the neonate.
Topics: Animals; Anuria; Dopamine; Furosemide; Glomerular Filtration Rate; Humans; Indomethacin; Infant, New | 1986 |
1 trial available for tolazoline and Oliguria
| Article | Year |
|---|---|
[Tolazoline and dopamine in the management of persistent fetal circulation].
Topics: Blood Circulation; Clinical Trials as Topic; Dopamine; Drug Interactions; Drug Therapy, Combination; | 1984 |
2 other studies available for tolazoline and Oliguria
| Article | Year |
|---|---|
[Tolazoline and dopamine in the treatment of the persistent fetal circulation syndrome].
Topics: Dopamine; Drug Therapy, Combination; Female; Humans; Hypotension; Infant, Newborn; Male; Oliguria; P | 1983 |
Oliguria and tolazoline pharmacokinetics in the newborn.
Topics: Animals; Anuria; Half-Life; Humans; Hyaline Membrane Disease; Hypertension, Pulmonary; Infant, Newbo | 1986 |